147 related articles for article (PubMed ID: 25518943)
1. Distinct metabolic responses of an ovarian cancer stem cell line.
Vermeersch KA; Wang L; McDonald JF; Styczynski MP
BMC Syst Biol; 2014 Dec; 8():134. PubMed ID: 25518943
[TBL] [Abstract][Full Text] [Related]
2. OVCAR-3 spheroid-derived cells display distinct metabolic profiles.
Vermeersch KA; Wang L; Mezencev R; McDonald JF; Styczynski MP
PLoS One; 2015; 10(2):e0118262. PubMed ID: 25688563
[TBL] [Abstract][Full Text] [Related]
3. The inhibitory effect of hypoxic cytotoxin on the expansion of cancer stem cells in ovarian cancer.
Nozawa-Suzuki N; Nagasawa H; Ohnishi K; Morishige K
Biochem Biophys Res Commun; 2015 Feb; 457(4):706-11. PubMed ID: 25619133
[TBL] [Abstract][Full Text] [Related]
4. Pyruvate uptake is increased in highly invasive ovarian cancer cells under anoikis conditions for anaplerosis, mitochondrial function, and migration.
Caneba CA; Bellance N; Yang L; Pabst L; Nagrath D
Am J Physiol Endocrinol Metab; 2012 Oct; 303(8):E1036-52. PubMed ID: 22895781
[TBL] [Abstract][Full Text] [Related]
5. Ovarian cancer stem cells: Molecular concepts and relevance as therapeutic targets.
Ahmed N; Abubaker K; Findlay JK
Mol Aspects Med; 2014 Oct; 39():110-25. PubMed ID: 23811037
[TBL] [Abstract][Full Text] [Related]
6. Spheroid cancer stem cells display reprogrammed metabolism and obtain energy by actively running the tricarboxylic acid (TCA) cycle.
Sato M; Kawana K; Adachi K; Fujimoto A; Yoshida M; Nakamura H; Nishida H; Inoue T; Taguchi A; Takahashi J; Eguchi S; Yamashita A; Tomio K; Wada-Hiraike O; Oda K; Nagamatsu T; Osuga Y; Fujii T
Oncotarget; 2016 May; 7(22):33297-305. PubMed ID: 27120812
[TBL] [Abstract][Full Text] [Related]
7. The use of plant-derived bioactive compounds to target cancer stem cells and modulate tumor microenvironment.
Pistollato F; Giampieri F; Battino M
Food Chem Toxicol; 2015 Jan; 75():58-70. PubMed ID: 25445513
[TBL] [Abstract][Full Text] [Related]
8. Hypoxia-induced metabolic shifts in cancer cells: moving beyond the Warburg effect.
Weljie AM; Jirik FR
Int J Biochem Cell Biol; 2011 Jul; 43(7):981-9. PubMed ID: 20797448
[TBL] [Abstract][Full Text] [Related]
9. Cancer stem cell metabolism.
Peiris-Pagès M; Martinez-Outschoorn UE; Pestell RG; Sotgia F; Lisanti MP
Breast Cancer Res; 2016 May; 18(1):55. PubMed ID: 27220421
[TBL] [Abstract][Full Text] [Related]
10. Docetaxel maintains its cytotoxic activity under hypoxic conditions in prostate cancer cells.
Forde JC; Perry AS; Brennan K; Martin LM; Lawler MP; Lynch TH; Hollywood D; Marignol L
Urol Oncol; 2012; 30(6):912-9. PubMed ID: 21176881
[TBL] [Abstract][Full Text] [Related]
11. Knockdown of creatine kinase B inhibits ovarian cancer progression by decreasing glycolysis.
Li XH; Chen XJ; Ou WB; Zhang Q; Lv ZR; Zhan Y; Ma L; Huang T; Yan YB; Zhou HM
Int J Biochem Cell Biol; 2013 May; 45(5):979-86. PubMed ID: 23416112
[TBL] [Abstract][Full Text] [Related]
12. Enhancement of cancer stem cell susceptibility to conventional treatments through complementary yoga therapy: possible cellular and molecular mechanisms.
Bhargav H; Metri K; Raghuram N; Ramarao NH; Koka PS
J Stem Cells; 2012; 7(4):261-7. PubMed ID: 24196800
[TBL] [Abstract][Full Text] [Related]
13. HIF expression and the role of hypoxic microenvironments within primary tumours as protective sites driving cancer stem cell renewal and metastatic progression.
Philip B; Ito K; Moreno-Sánchez R; Ralph SJ
Carcinogenesis; 2013 Aug; 34(8):1699-707. PubMed ID: 23740838
[TBL] [Abstract][Full Text] [Related]
14. Resveratrol inhibits glucose metabolism in human ovarian cancer cells.
Kueck A; Opipari AW; Griffith KA; Tan L; Choi M; Huang J; Wahl H; Liu JR
Gynecol Oncol; 2007 Dec; 107(3):450-7. PubMed ID: 17825886
[TBL] [Abstract][Full Text] [Related]
15. In vivo and in vitro properties of ovarian cancer cells.
Malek A
Methods Mol Biol; 2013; 1049():315-21. PubMed ID: 23913226
[TBL] [Abstract][Full Text] [Related]
16. SOX2 expression associates with stem cell state in human ovarian carcinoma.
Bareiss PM; Paczulla A; Wang H; Schairer R; Wiehr S; Kohlhofer U; Rothfuss OC; Fischer A; Perner S; Staebler A; Wallwiener D; Fend F; Fehm T; Pichler B; Kanz L; Quintanilla-Martinez L; Schulze-Osthoff K; Essmann F; Lengerke C
Cancer Res; 2013 Sep; 73(17):5544-55. PubMed ID: 23867475
[TBL] [Abstract][Full Text] [Related]
17. Hepatocyte nuclear factor-1β (HNF-1β) promotes glucose uptake and glycolytic activity in ovarian clear cell carcinoma.
Okamoto T; Mandai M; Matsumura N; Yamaguchi K; Kondoh H; Amano Y; Baba T; Hamanishi J; Abiko K; Kosaka K; Murphy SK; Mori S; Konishi I
Mol Carcinog; 2015 Jan; 54(1):35-49. PubMed ID: 24105991
[TBL] [Abstract][Full Text] [Related]
18. Metabolic signatures differentiate ovarian from colon cancer cell lines.
Halama A; Guerrouahen BS; Pasquier J; Diboun I; Karoly ED; Suhre K; Rafii A
J Transl Med; 2015 Jul; 13():223. PubMed ID: 26169745
[TBL] [Abstract][Full Text] [Related]
19. Role of the microenvironment in ovarian cancer stem cell maintenance.
Pasquier J; Rafii A
Biomed Res Int; 2013; 2013():630782. PubMed ID: 23484135
[TBL] [Abstract][Full Text] [Related]
20. Perspectives of Reprogramming Breast Cancer Metabolism.
Wang YP; Lei QY
Adv Exp Med Biol; 2017; 1026():217-232. PubMed ID: 29282686
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
